33.13 USD
↘ 0.15 (0.45%)LIVE (AS OF 01:54 PM EST)
Immunovant, Inc. Common Stock (IMVT) trades at $33.13 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, IMVT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 16, 2026.